Investor Sues Drug Company, Others Over Involvement In Price-Fixing Scheme

Mealey's (December 7, 2016, 9:25 AM EST) -- NEW YORK — A specialty pharmaceutical company and several of its current and former officers and directors concealed their involvement in an illegal generic drug price-fixing scheme in violation of federal securities laws, an investor argues in a Nov. 8 complaint filed in New York federal court (Charles R. Haile Jr. v. Allergan plc, et al., No. 16-8661, S.D. N.Y.)....